LPA and acute coronary syndrome: At baseline, aspirin was the most frequently reported, although the usage rates varied widely, from 36.7% and 31.6% in high and low Lp(a) groups, respectively, with acute coronary syndrome (ACS),27 to more than 80% in other populations (Supplemental Table 7).